The Histochemical Journal

, Volume 33, Issue 1, pp 19–24 | Cite as

In Situ Detection of 1,25-dihydroxyvitamin D Receptor In human Skeletal Muscle Tissue

  • H.A. Bischoff
  • M. Borchers
  • F. Gudat
  • U. Duermueller
  • R. Theiler
  • H.B. Stähelin
  • W. Dick


Growing evidence suggests that intracellular vitamin D receptors are present in skeletal muscle tissue mediating vitamin D hormone response. The aim of the work reported here was to investigate the in situ expression of 1,25-dihydroxy vitamin D3 receptor in human skeletal muscle tissue. Intraoperative periarticular muscle biopsies were taken from 20 female orthopaedic patients (17 middle-aged and elderly patients receiving total hip arthroplasty due to osteoarthritis of the hip or an osteoporotic hip fracture and 3 young patients who received back surgery). The immunohistological distribution of the vitamin D3 receptor was investigated using a monoclonal rat antibody to the receptor (Clone Nr. 9A7). The receptor-positive nuclei were quantified by counting 500 nuclei per biopsy. Strong intranuclear immunostaining of the vitamin D receptor was detected in human muscle cells. Biopsies of hip patients had significantly fewer receptor-positive nuclei compared to those of back surgery patients (Mann–Whitney U-test: p = 0.0025). VDR expression (number of antigen-positive nuclei) was significantly correlated with age (coefficient of correlation = 0.46; p = 0.005), but not with 25-hydroxyvitamin D or 1,25-dihydroxyvitamin D levels. The data clearly demonstrate presence of nuclear 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle. To our knowledge this is the first in situ detection of the receptor in human skeletal muscle. The difference in the expression of the receptor between hip and spinal muscle biopsies might be explained by age or location. Further research is needed in order to evaluate whether vitamin D3 receptor expression in human skeletal muscle is age-dependent and varies between different muscles.


Muscle Biopsy Human Skeletal Muscle Skeletal Muscle Tissue Back Surgery Spinal Muscle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Berger U, Wilson P, McClelland RA, Colston K, Haussler MR, Pike JW, Coombes RC (1988) Immunocytochemical detection of 1,25-dihydroxyvitamin D receptor in normal human tissues. J Clin Endocrinol Metab 67: 607–613.Google Scholar
  2. Berry JL, Farquharson C, Whitehead CC, Mawer EB (1996) Growth plate chondocyte vitamin D receptor number and affinity are reduced in avian tibial dyschondroplastic lesions. Bone 19: 197–203.Google Scholar
  3. Bischoff HA, Stähelin HB, Urscheler N, Ehrsam R, Vonthein R, Perrig-Chiello P, Tyndall A, Theiler R (1999) Muscle strength in the elderly: ist relationship to vitamin D metabolites. Arch Phys Med Reha 80: 54–58.Google Scholar
  4. Boland R (1986) Role of vitamin D in skeletal muscle function. Endocrine Reviews 7: 434–448.Google Scholar
  5. Boland R, Norman A, Ritz E, Hasselbach W (1985) Presence of a 1,25-dihydroxyvitamin D3 receptor in chick skeletal muscle myoblasts. Biochem Biophys Res Commun 128: 305.Google Scholar
  6. Byers PD, Contepenni CA, Farkas TA (1976) A postmortem study of the hip joint. Ann Rheum Dis 29: 15–31.Google Scholar
  7. Colston KW, Mackay AG, Finlayson C, Wu JC, Maxwell JD (1994) Localisation of vitamin D receptor in normal human duodenum and in patients with coeliac disease. Gut 35: 1219–1225.Google Scholar
  8. Costa EM, Blau HM, Feldman D (1986) 1,25-Dihydroxyvitamin D3 receptors and hormonal responses in cloned human muscle cells. Endocrinology 119: 2214–2220.Google Scholar
  9. D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, Sinigaglia F, Panina-Bordignon P (1998) Inhibition of IL-12 Production by 1,25-dihydroxyvitamin D3. J Clin Invest 101: 252–262.Google Scholar
  10. Elder GC, Bradbury K, Roberts R. Variability of fiber type distributions within human muscles (1982). J Appl Physiol 6: 1473–1480.Google Scholar
  11. Foss MVL, Byers PD (1972) Bone density, osteoarthritis of the hip and fracture of the upper end of the femur. Ann Rheum Dis 31: 259–264.Google Scholar
  12. Geusens P, Vandevyver C, Vanhoof J, Cassiman JJ, Boonen S, Raus J (1997). Quadriceps and grip strength are related to vitamin D receptor genotype in elderly nonobese women. J Bone Miner Res 12: 2082–2088.Google Scholar
  13. Haussler MR, Jurutka PW, Hsieh JC, Thompson PD, Selznick SH, Haussler CA, Whitfield GK (1995) New understanding of the molecular mechanisms of receptor-mediated genomic actions of the vitamin D hormone. Bone 17: 335–385.Google Scholar
  14. Horst RL, Goff JP, Reinhardt TA (1990) Advancing age results in reduction of intestinal and bone 1,25-dihydroxyvitamin D receptor. Endocrinology 126: 1053–1057.Google Scholar
  15. Johnson JA, Grande JP, Roche PC, Kumar R(1996) Immunohistochemical detection and distribution of the 1,25-dihydroxyvitamin D3 receptor in rat reproductive tissues. Histochem Cell Biol 105: 7–15.Google Scholar
  16. Lips P, Netelenbos JC, Jongen MJM (1982) Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metab Bone Dis Rel Res 4: 85–93.Google Scholar
  17. Levy FO, Eikvar L, Froysa A, Hansson V (1985) “Differential displacement” – a simple method to study receptors for 1,25-dihydroxyvitamin D3 in the presence of contaminating serum vitamin D binding protein. Biochem Biophys Res Commun 130: 1020.Google Scholar
  18. McKenna MJ (1992) Difference in vitamin d status between countries in young adults and the elderly. Am J Med 93: 69–77.Google Scholar
  19. Minghetti PP, Norman AW (1982) 1,25(OH)2-vitamin D3receptors: gene regulation and genetic circuitry. FASEB J 2: 3043–3053.Google Scholar
  20. Moulias R, Meaume S, Raynaud-Simon A (1999) Sarcopenia, hypermetabolism, and aging. Z Geronol Geriatr 32: 425–432.Google Scholar
  21. O'Connell TD, Simpson RU (1996) Immunochemical identification of the 1,25-dihydroxyvitamin D3 receptor protein in human heart. Cell Biol Int 20: 621–624.Google Scholar
  22. Pike JW (1992) Molecular mechanisms of cellular response to the vitamin D3 hormone. Disorders of Bone and Mineral Metabolism Chapter 8: 163–193.Google Scholar
  23. Pogrung H, Rutemberg M, Makin M, Robin G, Menczel J, Steinberg R (1982) Osteoarthritis of the hip joint and osteoporosis. Clin Orthop Rel Res 164: 130–135.Google Scholar
  24. Reichrath J, Collins ED, Epple S, Kerber A, Norman AW, Bahmer FA (1996) Immunohistochemical detection of 1,25-dihydroxyvitamin D3 receptor (VDR) in human skin. Acomparison of five antibodies.Pathol Res Pract 192: 281–289.Google Scholar
  25. Reichrath J, Rafi L, Muller SM, Mink D, Reitnauer K, Tilgen W, Schmidt W, Friedrich M (1998) Immunohistochemical analysis of 1,25-dihydroxyvitamin D3 receptor in cervical carcinoma. Histochem J 30: 561–567.Google Scholar
  26. Sørensen OH, Lund BI, Saltin B, Andersen RB, Hjorth L, Melsen F, Mosekilde L (1979) Myopathy in bone loss of ageing: improvement by treatment with 1α-hydroxycholecalciferol and calcium. Clinical Science 56: 157–161.Google Scholar
  27. Schott GD, Wills MR (1976) Muscle weakness in osteomalacia. Lancet 1: 626–629.Google Scholar
  28. Simpson RU, Thomas GA, Arnold AJ (1985) Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem 260: 8882–8891.Google Scholar
  29. Theiler R, Stahelin HB, Kranzlin M, Somorjai G, Singer-Lindpaintner L, Conzelmann M, Geusens P, Bischoff HA (2000) Influence of physical mobility and season on 25-hydroxyvitamin D-parathyroid hormone interaction and bone remodelling in the elderly. Eur J Endocrinol 143: 673–679.Google Scholar
  30. Van der Wielen RPJ, Löwik MRH, van der Berg H, CPGM de Groot L, Haller J, Moreiras O, van Staveren WA (1995) Serum vitamin D concentrations among elderly people in Europe. Lancet 346: 207–210.Google Scholar
  31. Walters MR (1992) Newly identified actions of the vitamin D endocrine system. Endocrine Reviews 13: 719–764.Google Scholar
  32. Wehling M (1994) Nongenomic actions of steroid hormones. TEM 5: 347–353.Google Scholar

Copyright information

© Kluwer Academic Publishers 2001

Authors and Affiliations

  • H.A. Bischoff
    • 1
  • M. Borchers
    • 1
  • F. Gudat
    • 2
  • U. Duermueller
    • 2
  • R. Theiler
    • 3
  • H.B. Stähelin
    • 4
  • W. Dick
    • 1
  1. 1.Department of OrthopedicsUniversity BaselSwitzerland
  2. 2.Department of PathologyUniversity BaselSwitzerland
  3. 3.Department of RheumatologyUniversity BaselSwitzerland
  4. 4.Department of GeriatricsUniversity BaselSwitzerland

Personalised recommendations